Publications 2026

Wei Q, Hajjar E, Cornillot-Clément S, Solli E, García-Díaz N, Landskron J, Gade A, Ahmad R, Taskén K (2026)
High-Throughput Phenotypic Screen to Identify FoxP3 Regulators in Primary T Cells
ACS Chem Biol, 21 (4), 764-778
DOI 10.1021/acschembio.5c01019, PubMed 41930720

Publications 2025

García-Díaz N, Solli E, Hajjar E, Cornillot-Clément S, Landskron J, Ahmad R, Wei Q, Taskén K (2025)
MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell Function
Eur J Immunol, 55 (2), e202451225
DOI 10.1002/eji.202451225, PubMed 39955647

Wei Q, Foyn H, Landskron J, Wang S, Rye IH, Skånland SS, Russnes HEG, Klaveness J, Ahmad R, Taskén K (2025)
Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3
iScience, 28 (3), 111931
DOI 10.1016/j.isci.2025.111931, PubMed 40034859

Publications 2023

García-Díaz N, Wei Q, Taskén K (2023)
Small molecule inhibitors targeting regulatory T cells for cancer treatment
Eur J Immunol, 54 (2), e2350448
DOI 10.1002/eji.202350448, PubMed 37937687

Publications 2022

Wei Q, Taskén K (2022)
Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development
Biochem J, 479 (20), 2219-2260
DOI 10.1042/BCJ20210233, PubMed 36305711